An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene
Open Access
- 1 January 2015
- journal article
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2015 (1) , 140105
Abstract
Summary: A patient of Cushing's disease (CD) characterized by a large tumor and only subtle symptoms of hormonal hypersecretion was examined. The patient had a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene. A 50-year-old male presenting with headache was diagnosed with a large pituitary tumor by magnetic resonance imaging (MRI). His visual fields were intact and he exhibited no features of CD. Owing to an exuberant response to synacthen, an overnight dexamethasone suppression test was performed revealing inadequate suppression of plasma cortisol (419 nmol/l). Owing to tumor growth and visual field impairment, he underwent transsphenoidal surgery and developed hypocortisolemia. The pathology specimen revealed a sparsely granulated corticotrope adenoma. Postoperative MRI showed a large tumor remnant. The patient developed skin hyperpigmentation and a synacthen test demonstrated high basal and stimulated cortisol levels; an overnight dexamethasone suppression test showed no suppression (791 nmol/l) and elevated plasma ACTH levels (135 ng/l). A transcranial operation was performed followed by radiotherapy. Two months after radiotherapy, he developed secondary adrenocortical failure. Genetic testing revealed an AIP variant of unknown significance (p.R16H) without loss of the normal AIP allele in the tumor. A literature review showed ten CD patients with AIP gene variants, of whom five (including our case) were p.R16H. CD is occasionally dominated by pituitary tumor growth rather than symptoms of hypersecretion. The particular AIP gene variant identified in our patient is shared by four other reported cases of CD. Future studies are needed to assess whether the reported AIP gene variant is more than just coincidental. Learning points: CD is occasionally dominated by pituitary tumor growth rather than symptoms of hypersecretion. Resolution of both tumor remnant and hormonal hypersecretion may occur within 2 months after postoperative radiotherapy. The particular AIP gene variant identified in our patient is shared by four other reported cases of CD.Keywords
This publication has 12 references indexed in Scilit:
- The FKBP-Type Domain of the Human Aryl Hydrocarbon Receptor-Interacting Protein Reveals an Unusual Hsp90 InteractionBiochemistry, 2013
- Clinicopathological Correlations in Pituitary AdenomasBrain Pathology, 2012
- Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 PatientsThe Journal of Clinical Endocrinology & Metabolism, 2012
- AIP and its interacting partnersJournal of Endocrinology, 2011
- The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromesClinical Genetics, 2010
- Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutationsProceedings of the National Academy of Sciences, 2007
- Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting MacroadenomasThe Journal of Clinical Endocrinology & Metabolism, 2005
- Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus1The Journal of Clinical Endocrinology & Metabolism, 1998
- Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndromeEuropean Journal of Endocrinology, 1993
- Rapid Appearance of Transient Secondary Adrenocortical Insufficiency After Alpha-Particle Radiation Therapy for Cushing's DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1976